← Back to the feed
Earnings4512WAKAMOTO PHARMACEUTICAL CO.,LTD.

Wakamoto Pharmaceutical Reports Q1 FY2027 Earnings Presentation: Revenue of 1.2 billion

– WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512.T) released its earnings presentation for Q1 FY2027.

Revenue was ¥1.2 billion. Operating profit was ¥140 million. Net profit was ¥6 million.

Total assets stood at ¥15.9 billion.

Financial results — FY2027/3 (consolidated)

MetricCurrentYoY
Revenue¥2,425M+11.9%
Operating profit¥-136Mn/a
Net profit¥6Mn/a

Next period forecast

Revenue

¥11,000M

+11.0%

Op. profit

¥200M

-21.7%

Net profit

¥230M

+1.2%

Figures in millions of yen

PDFOriginal disclosure15:30 JSTView original ↗
End of article